February 3, 2014 | Israeli company MediWound, which develops treatments for burns and wounds, has announced that it has filed a draft prospectus for an offering on Nasdaq. The company will hold the IPO at a company value of $400 million (before money) and attempt to raise $100 million. The majority shareholder of the company is Clal Biotechnology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Clean Energy Company That Mimics The Sun Raises $22M
February 02, 2023

Blood Test Offers Hope For Lung Cancer Patients
February 02, 2023

Israel Opens Its First Satellite Observatory
February 02, 2023

Cloud Data-Securing Startup Raises $30M
February 01, 2023
Facebook comments